3-[2-[1-(3,6-dimethyl-4-oxo-2-phenylchromen-8-yl)ethylamino]-6-fluorophenyl]-4H-1,2,4-oxadiazol-5-one
C27H22FN3O4 — CID 169269465
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[2-[1-(3,6-dimethyl-4-oxo-2-phenylchromen-8-yl)ethylamino]-6-fluorophenyl]-4H-1,2,4-oxadiazol-5-one
3-[2-[1-(3,6-dimethyl-4-oxo-2-phenylchromen-8-yl)ethylamino]-6-fluorophenyl]-4H-1,2,4-oxadiazol-5-one (PubChem CID 169269465) has the molecular formula C27H22FN3O4 and a molecular weight of 471.49 g/mol. Its IUPAC name is 3-[2-[1-(3,6-dimethyl-4-oxo-2-phenylchromen-8-yl)ethylamino]-6-fluorophenyl]-4H-1,2,4-oxadiazol-5-one.
Molecular Properties
| Compound Name | 3-[2-[1-(3,6-dimethyl-4-oxo-2-phenylchromen-8-yl)ethylamino]-6-fluorophenyl]-4H-1,2,4-oxadiazol-5-one |
|---|---|
| PubChem CID | 169269465 |
| Molecular Formula | C27H22FN3O4 |
| Molecular Weight | 471.49 g/mol |
| Exact Mass | 471.16 |
| IUPAC Name | 3-[2-[1-(3,6-dimethyl-4-oxo-2-phenylchromen-8-yl)ethylamino]-6-fluorophenyl]-4H-1,2,4-oxadiazol-5-one |
| SMILES | Cc1cc(C(C)Nc2cccc(F)c2-c2noc(=O)[nH]2)c2oc(-c3ccccc3)c(C)c(=O)c2c1 |
| InChI | InChI=1S/C27H22FN3O4/c1-14-12-18(16(3)29-21-11-7-10-20(28)22(21)26-30-27(33)35-31-26)25-19(13-14)23(32)15(2)24(34-25)17-8-5-4-6-9-17/h4-13,16,29H,1-3H3,(H,30,31,33) |
| InChIKey | HGVPNRAHAZDEDA-UHFFFAOYSA-N |
| XLogP | 5.73 |
| TPSA | 101.13 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 471.49 |
| LogP ≤ 5 | 5.73 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 169269465 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.